Your browser doesn't support javascript.
loading
Dolaflexin: A Novel Antibody-Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect.
Yurkovetskiy, Aleksandr V; Bodyak, Natalya D; Yin, Mao; Thomas, Joshua D; Clardy, Susan M; Conlon, Patrick R; Stevenson, Cheri A; Uttard, Alex; Qin, LiuLiang; Gumerov, Dmitry R; Ter-Ovanesyan, Elena; Bu, Charlie; Johnson, Alex J; Gurijala, Venu R; McGillicuddy, Dennis; DeVit, Michael J; Poling, Laura L; Protopopova, Marina; Xu, Ling; Zhang, Qingxiu; Park, Peter U; Bergstrom, Donald A; Lowinger, Timothy B.
Affiliation
  • Yurkovetskiy AV; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Bodyak ND; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Yin M; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Thomas JD; Mersana Therapeutics, Cambridge, Massachusetts.
  • Clardy SM; Mersana Therapeutics, Cambridge, Massachusetts.
  • Conlon PR; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Stevenson CA; Mersana Therapeutics, Cambridge, Massachusetts.
  • Uttard A; Mersana Therapeutics, Cambridge, Massachusetts.
  • Qin L; Mersana Therapeutics, Cambridge, Massachusetts.
  • Gumerov DR; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Ter-Ovanesyan E; Mersana Therapeutics, Cambridge, Massachusetts.
  • Bu C; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Johnson AJ; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Gurijala VR; Mersana Therapeutics, Cambridge, Massachusetts.
  • McGillicuddy D; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • DeVit MJ; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Poling LL; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Protopopova M; Mersana Therapeutics, Cambridge, Massachusetts.
  • Zhang Q; Mersana Therapeutics, Cambridge, Massachusetts.
  • Park PU; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Bergstrom DA; Formerly Mersana Therapeutics, Cambridge, Massachusetts.
  • Lowinger TB; Mersana Therapeutics, Cambridge, Massachusetts. tlowinger@mersana.com.
Mol Cancer Ther ; 20(5): 885-895, 2021 05.
Article in En | MEDLINE | ID: mdl-33722857
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Polymers / Immunoconjugates Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Polymers / Immunoconjugates Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2021 Type: Article